Tilray Shares Surge 32% Amid Cannabis Sector Catalysts
Tilray Brands Inc. shares rallied 31.55% to $11.09 in after-hours trading following dual catalysts: the launch of premium vape products and potential federal cannabis policy reform. The cannabis company unveiled its Amped Live Resin Liquid Diamond vape cartridge line through subsidiary Redecan, featuring ceramic-core technology and high-potency formulations.
Market sentiment strengthened further with reports the Biden administration may reclassify marijuana from Schedule I to Schedule III. Tilray's regular session gain of 2.1% accelerated post-market as traders priced in improved regulatory prospects for the sector.
Analysts maintain a Hold rating with $20 average price target, suggesting skepticism about sustainability of the rally. The new product line targets Canada's premium cannabis segment during peak seasonal demand periods.